4 free views remaining today
lateral sclerosis
ICD-10 Codes
Related ICD-10:
Description
What is Lateral Sclerosis?
Lateral sclerosis, also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord [4]. It leads to muscle weakness, wasting, and eventually paralysis [3].
Characteristics of Lateral Sclerosis
- Progressive degeneration: The disease gets worse over time, with symptoms gradually worsening as the nerve cells continue to die [1].
- Muscle weakness: ALS causes loss of muscle control, leading to weakness in the muscles that control movement, speech, and breathing [3].
- Neurodegeneration: The disease affects motor neurons, which are specialized nerve cells that control muscle movement [6].
Key Terms
- "Lateral" refers to the location of the damage in the spinal cord, specifically the lateral columns [7].
- "Sclerosis" means "hardened" and refers to the hardened nature of the spinal cord in advanced ALS [5].
In summary, lateral sclerosis is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, wasting, and eventual paralysis.
Additional Characteristics
- A progressive neurodegenerative disease
- Affects nerve cells in the brain and spinal cord
- Leads to muscle weakness, wasting, and eventually paralysis
- Characterized by progressive degeneration
- Causes loss of muscle control and weakness
- Affects motor neurons that control muscle movement
- Located in the lateral columns of the spinal cord
Signs and Symptoms
Symptoms of Lateral Sclerosis
Lateral sclerosis, also known as Amyotrophic Lateral Sclerosis (ALS), is a progressive neurological disorder that affects nerve cells in the brain and spinal cord. The symptoms of ALS vary from person to person, but they generally begin with weakness or stiffness in the legs, arms, or other muscles.
- Early Symptoms: Early signs of ALS may include:
- Weakness or numbness in the face, arm, or leg [1]
- Difficulty speaking or swallowing [2]
- Muscle cramps and twitches [3]
- Fatigue or weakness in the arms and/or legs [4]
- Progressive Symptoms: As the disease progresses, symptoms can affect various parts of the body, including:
- Loss of muscle mass and strength
- Difficulty walking or maintaining balance
- Slurred speech or difficulty swallowing
- Weakness or paralysis in the face, arm, or leg [5]
- Other Symptoms: Some people with ALS may experience other symptoms, such as:
- Tripping or falling due to weakness or numbness in the legs
- Difficulty breathing or experiencing shortness of breath
- Abnormal fatigue or weakness in the arms and/or legs
Important Note: The progression and severity of symptoms can vary significantly from person to person. If you are experiencing any of these symptoms, it is essential to consult a healthcare professional for proper diagnosis and treatment.
References: [1] Context 1: Symptoms depend on which nerve cells are affected. [2] Context 2: ALS affects motor neurons, the nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing. [3] Context 6: Other early symptoms vary but can include tripping, dropping things, abnormal fatigue of the arms and/or legs, slurred speech, muscle cramps and twitches [4] Context 7: Over months and years, people with ALS lose the ability to control voluntary muscle movement throughout their body... [5] Context 9: The early symptoms of ALS tend to affect your extremities or sometimes your breathing and eating.
Additional Symptoms
- Difficulty walking or maintaining balance
- Muscle cramps and twitches
- Slurred speech or difficulty swallowing
- Weakness or numbness in the face, arm, or leg
- Difficulty speaking or swallowing
- Loss of muscle mass and strength
- or legs
- Weakness or paralysis in the face, arm, or leg
- Difficulty breathing or experiencing shortness of breath
- weakness
Diagnostic Tests
Diagnosing Lateral Sclerosis: A Comprehensive Overview
Lateral sclerosis, also known as amyotrophic lateral sclerosis (ALS), can be a challenging disease to diagnose due to its similar symptoms with other neurological conditions. However, various diagnostic tests can help confirm the presence of ALS.
- No single test confirms ALS: Unlike some other diseases, there is no single test that can definitively diagnose ALS [2]. Instead, a combination of clinical signs and symptoms, along with laboratory tests, are used to make a diagnosis.
- Electrodiagnostic tests: These include electomyography (EMG) and nerve conduction velocity (NCV), which help assess the electrical activity of nerves and muscles [6][7][8]. EMG tests can detect abnormal muscle activity, while NCV measures the speed at which electrical signals travel through nerves.
- Blood and urine studies: These may be performed to rule out other potential causes of symptoms, such as blood tests for electrolyte imbalances or urine tests for kidney function [5].
- Imaging tests: While not definitive, imaging tests like ultrasound can detect fasciculations (muscle twitching) that may aid in the diagnosis of ALS [12].
Diagnostic Criteria
The diagnosis of ALS requires the presence of signs of lower motor neuron degeneration by clinical, electrophysiological, or neuropathologic examination [13]. This typically involves a combination of:
- Clinical evaluation: A thorough medical history and physical exam to assess muscle strength and reflexes.
- Electrophysiological tests: EMG and NCV to evaluate nerve function.
- Neuropathologic examination: Examination of tissue samples from the brain or spinal cord.
Conclusion
Diagnosing lateral sclerosis, specifically ALS, involves a comprehensive approach that combines clinical evaluation, laboratory tests, and imaging studies. While there is no single test that confirms ALS, a combination of these methods can help make an accurate diagnosis.
Treatment
Treatment Options for Lateral Sclerosis
Lateral sclerosis, also known as amyotrophic lateral sclerosis (ALS), is a progressive neurological disease that affects nerve cells in the brain and spinal cord. While there is no cure for ALS, various drug treatments can help manage symptoms and slow down disease progression.
Approved Medications
There are currently three medications approved by the U.S. Food and Drug Administration (FDA) to treat ALS:
- Riluzole: This medication was first approved in 1995 and has been shown to extend life expectancy in patients with ALS. It works by blocking glutamate release, which can help slow down disease progression.
- Edaravone: Approved in 2017, edaravone is a free radical scavenger that helps reduce oxidative stress and inflammation in the brain and spinal cord.
- Tofersen (Qalsody): This medication was approved in 2023 for patients with ALS associated with a mutation in the superoxide dismutase 1 (SOD1) gene. Tofersen is an antisense oligonucleotide that targets the SOD1 gene, reducing its expression and slowing down disease progression.
Other Treatment Options
In addition to these approved medications, other treatments may be used to manage symptoms and improve quality of life for patients with ALS:
- Baclofen: This medication can help relieve limb stiffness and spasms.
- Tizanidine: Another antispasticity agent that can help reduce muscle tone and spasm.
- Relyvrio: A recently approved medication that has shown promise in slowing down disease progression.
Expanded Access
For patients with ALS who have tried other treatment options, expanded access programs may be available. These programs allow patients to gain access to investigational medications outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
References:
- [1] FDA approval for Riluzole (1995)
- [2] FDA approval for Edaravone (2017)
- [3] FDA approval for Tofersen (2023)
- [4] ALS Association Funded Antisense Technology Behind Tofersen
- [5] Current pharmacological approaches to ALS/MND
Differential Diagnosis
The differential diagnosis of lateral sclerosis, specifically primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS), involves a wide range of conditions that can present with similar symptoms.
Conditions to Consider
- Hereditary spastic paraparesis (HSP): A genetic disorder that affects the spinal cord, leading to progressive weakness and stiffness in the legs [10].
- Konzo: A rare neurological disorder caused by cyanide poisoning from cassava consumption, which can lead to muscle weakness and paralysis [6].
- Neurolathyrism: A condition caused by eating lathyrus sativus (grass pea), leading to progressive motor neuron disease [6].
- Spinocerebellar ataxias: A group of genetic disorders that affect the cerebellum, leading to problems with coordination and balance [6].
- Tumors of the spinal cord: Certain types of tumors can compress or damage the spinal cord, leading to symptoms similar to PLS or ALS [3].
Other Conditions
- Musculoskeletal conditions: Such as musculotendinous injuries or osteoarthritis, which can mimic the symptoms of PLS or ALS [8].
- Neurological conditions: Like multiple sclerosis, Guillain-Barré syndrome, and myasthenia gravis, which can present with similar symptoms to PLS or ALS [4, 9].
Key Points
- The differential diagnosis of PLS and ALS is broad and requires a thorough evaluation of the patient's medical history, physical examination, and laboratory tests.
- A correct diagnosis is essential for providing appropriate management and treatment plans for patients with PLS or ALS.
References:
[1] Context result 10 [3] Context result 3 [4] Context result 4 [6] Context result 6 [8] Context result 8 [9] Context result 9 [10] Context result 10
Additional Differential Diagnoses
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- Xref MGI.
- oboInOwl#id
- DOID:230
- core#notation
- DOID:230
- oboInOwl#hasDbXref
- UMLS_CUI:C0154682
- IAO_0000115
- A motor neuron disease characterized by painless but progressive weakness and stiffness of the muscles of the legs.
- oboInOwl#hasExactSynonym
- primary lateral sclerosis
- rdf-schema#label
- lateral sclerosis
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- t418364
- RO_0002452
- http://purl.obolibrary.org/obo/SYMP_0000363
- relatedICD
- http://example.org/icd10/G12.23
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_9700
- owl#annotatedSource
- t417958
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.